Nair D, Gupta N, Kabra S, Ahuja R B, Prakash S K
Department of Burns and Plastic Surgery, Lok Nayak Hospital and associated Maulana Azad Medical College, New Delhi, India.
Burns. 1999 Dec;25(8):723-7. doi: 10.1016/s0305-4179(99)00064-9.
This is the first report of Salmonella senftenberg serovar outbreak in a burns unit. This unit admits about 2000 patients with major burn injuries annually. Routine sampling from wound swabs in December 1995 revealed S. senftenberg in a few samples following which a study was instituted from January to March 1996. Of 446 burn admissions during this period 80 patients were culture positive for S. senftenberg in wound swabs. The protocol for investigation included wound swabs on admission and then at biweekly interval, blood culture studies on clinically toxic patients, anti-microbial sensitivity studies, environmental sampling and hand swabs and stool cultures from about 50 staff members of the burns ward. No wound swab at the time of admission was positive for S. senftenberg. Environmental study and the study of staff members did not reveal any obvious source of the infection. S. senftenberg strains were sensitive to more than seven of the 11 anti-microbials tested at the beginning of the study but later 96.3% of the strains showed multidrug (more than three drugs) resistance. By April 1996 the isolates became negligible and later disappeared completely. The organism resurfaced again in March 1997 and the same study was instituted again on 413 admissions between March and May 1997. Fifty patients were culture positive for S. senftenberg. This time stool sample from one burn dresser tested positive for S. senftenberg. Interestingly, again at the beginning of the second outbreak the Salmonella strains were sensitive to 9 out of 11 anti-microbials tested, but later 96.11% strains became multidrug resistant. S. senftenberg strains showed maximum resistance to amoxycillin (97.5%) and minimum to chloramphenicol, tetracycline and cotrimoxazole (12%). It was noticed that Salmonella strains surfaced in wound swabs after 3-4 weeks of hospital stay. Forty-five out of 130 patients studied, in both the episodes, died due to septicemia. The majority of the patients who died had sustained > 60% TBSA burns. Blood cultures were done in 34/130 patients and eight yielded growth (2 S. senftenberg, 4 Klebsiella spp., and two Pseudomonas spp.)
这是关于森夫滕贝格沙门氏菌血清型在烧伤病房暴发的首份报告。该病房每年收治约2000例重度烧伤患者。1995年12月对伤口拭子进行常规采样时,在少数样本中发现了森夫滕贝格沙门氏菌,随后于1996年1月至3月开展了一项研究。在此期间收治的446例烧伤患者中,80例患者的伤口拭子森夫滕贝格沙门氏菌培养呈阳性。调查方案包括入院时及之后每两周采集一次伤口拭子,对有临床中毒症状的患者进行血培养研究、抗菌药敏研究、环境采样以及对烧伤病房约50名工作人员进行手部拭子和粪便培养。入院时的伤口拭子均未检测出森夫滕贝格沙门氏菌阳性。环境研究和工作人员研究均未发现明显的感染源。在研究开始时,森夫滕贝格沙门氏菌菌株对所测试的11种抗菌药物中的7种以上敏感,但后来96.3%的菌株表现出多重耐药(对三种以上药物耐药)。到1996年4月,分离株数量变得极少,随后完全消失。该病菌于1997年3月再次出现,1997年3月至5月期间对413例入院患者再次开展了相同研究。50例患者的森夫滕贝格沙门氏菌培养呈阳性。此次,一名烧伤换药员的粪便样本检测出森夫滕贝格沙门氏菌阳性。有趣的是,在第二次暴发开始时,所测试的11种抗菌药物中有9种对沙门氏菌菌株敏感,但后来96.11%的菌株出现多重耐药。森夫滕贝格沙门氏菌菌株对阿莫西林的耐药性最高(97.5%),对氯霉素、四环素和复方新诺明的耐药性最低(12%)。据观察,沙门氏菌菌株在住院3 - 4周后出现在伤口拭子中。在这两次事件中研究的130例患者中有45例死于败血症。大多数死亡患者的烧伤总面积超过60%。130例患者中有34例进行了血培养,8例培养出细菌(2例为森夫滕贝格沙门氏菌、4例为克雷伯菌属、2例为假单胞菌属)